Skip to content

Cytokine Alterations and Chronic Post-Surgical Pain

WithdrawnNCT06418295
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Chronic Post-Surgical Pain (CPSP) is a condition that involves experiencing pain and/or discomfort that lasts for more than 3 months following surgery without any explainable cause of this pain such chronic infection or pain caused from a condition preceding surgery. This condition negatively impacts health related quality of life and is associated with significant financial burden both for the patient and health care system. Patients undergoing common surgeries such as amputation, breast surgery, hernia repair, coronary artery bypass, and caesarean section can be prone to developing CPSP. CPSP may be caused by the release and expression of different cellular molecules called cytokines and chemokines that can cause a pain response when they are present in the body at certain levels. After surgical incision, tissue cells have been shown to release cytokines and chemokines, thus increasing the concentration of these molecules in the patient's blood. It is not entirely known what mechanisms cause the increased expression of chemokines and cytokines. One method that may play a role in in this expression is epigenetics which is the alteration of gene expression without permanently altering the structure of DNA. Unlike mutations, epigenetic changes are dynamic, possibly reversible, and are influenced by environmental and behavioral changes such as diet, exercise, disease, stress, toxin exposure etc. Epigenetic changes occur all throughout our life and have been associated with several disease processes such as cancer, diabetic complications, and chronic pain. At the molecular level, certain events take place that can regulate (increase or decrease) the expression of cytokines and chemokines, most notably DNA methylation of their promotor (which involves adding molecules to DNA that does not change its structure but changes it's activity). The investigators are conducting this study to determine if the alteration of specific cytokines are associated with the occurrence of …

Study details

Official title
Cytokine Alterations Associated With Persistent Post-surgical Pain and Their Regulation Through Epigenetic Changes - A Pilot Study
Interventions
  • Other: Unilateral thoracotomy
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Start date
2026-01-01
Primary completion
2028-12-01
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. 18 years of age or older 2. Undergoing unilateral thoracotomy for the first time on that side 3. Willing to provide informed consent for study participation. 4. Patient with malignancy that needs thoracotomy for surgical resection. Exclusion Criteria: 1. Chronic pain prior to surgery 2. Pre-existing fibromyalgia 3. Long-term opioid use 4. Diabetes mellitus 5. Inflammatory bowel disease 6. Pre-existing neurological disease 7. Pre-existing nerve injury 8. Evidence of dementia, delirium or cognitive disorder that may interfere with study participation 9. Malignancy other than lung cancer 10. Autoimmune disorder (e.g. rheumatoid arthritis and psoriatic arthritis) 11. Pregnancy 12. Inability to communicate in the English language (required for completion of questionnaires and provision of pain scores). 13. Patents on antiepileptic medications

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06418295